Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration.
Gori, A M
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration. [electronic resource] - British journal of haematology Jun 2002 - 693-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1046/j.1365-2141.2002.03522.x doi
Adult
Aged
Angina, Unstable--blood
Anticoagulants--therapeutic use
Antithrombin III--metabolism
Drug Administration Schedule
Enoxaparin--therapeutic use
Female
Fibrinolytic Agents--therapeutic use
Humans
Lipoproteins--blood
Male
Middle Aged
Peptide Fragments--metabolism
Peptide Hydrolases--metabolism
Protein Precursors--metabolism
Prothrombin--metabolism
Thromboplastin--metabolism
Tissue Plasminogen Activator--blood
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration. [electronic resource] - British journal of haematology Jun 2002 - 693-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1046/j.1365-2141.2002.03522.x doi
Adult
Aged
Angina, Unstable--blood
Anticoagulants--therapeutic use
Antithrombin III--metabolism
Drug Administration Schedule
Enoxaparin--therapeutic use
Female
Fibrinolytic Agents--therapeutic use
Humans
Lipoproteins--blood
Male
Middle Aged
Peptide Fragments--metabolism
Peptide Hydrolases--metabolism
Protein Precursors--metabolism
Prothrombin--metabolism
Thromboplastin--metabolism
Tissue Plasminogen Activator--blood